Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eptacog beta (Sevenfact) in Glanzmann Thrombasthenia
NCT07136857Phase 2Recruiting
- Sponsor
- Emory University
- Start
- Oct 2025
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of coagulation factor VIIa in Glanzmann thrombasthenia (GT), sponsored by Emory University. Started Oct 2025; status: recruiting.
02
Drugs
coagulation factor VIIa
03
Conditions
Glanzmann thrombasthenia (GT)
Beyond the preview
Go deeper on NCT07136857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07136857.